Article By:
ChinaBio® Today
Saturday, June 15, 2024 1:40 PM EDT
Shionogi, an Osaka innovative pharma, has signed an option agreement with Cilcare of France to in-license two drug candidates aimed at hearing loss in a deal worth up to $445 million. Meanwhile, XtalPi raised $126.8 million in a Hong Kong IPO.
Will Chamath Finally Do A Deal For His IPOF SPAC? (19 Months Later)
I will soon! $VYGG is a SPAC $XAIR due for FDA ruling and $ZYME just rebuffed a takeover bid...